Stake Announced
Oberland Capital Management stake in MeiraGTx Holdings
Announced Jul 2026 · NASDAQ: MGTX
Advisers
Oberland Capital Management
Acquirer
Not disclosed
- Target
- MeiraGTx Holdings
- Acquirer
- Oberland Capital Management
- Target based in
- United States
- Buyer based in
- United States
- Structure
- Minority stake
- Sector
- Biotech
- Tags
- Biotech, Life Sciences
In the league tables
Similar deals
- BRUKER acquisition of MIMETAS Aug 2026 · Life Sciences
- Eli Lilly and Company acquisition of Sangamo Therapeutics capsid delivery, zinc finger, modular integrase platforms and prion disease program Jun 2026 · Biotech
- Ligand Pharmaceuticals acquisition of XOMA Royalty Apr 2026 · US$739m · Specialty finance and leasing
- XRA 7 Corp. acquisition of Generation Bio Co. Dec 2025 · Biotech
- Invex Therapeutics acquisition of Rekover Therapeutics Oct 2026 · Healthcare
